GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » Total Operating Expense

Diasorin SpA (CHIX:DIAM) Total Operating Expense : €519 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Diasorin SpA Total Operating Expense?

Diasorin SpA's Total Operating Expense for the three months ended in Mar. 2025 was €131 Mil. Diasorin SpA's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €519 Mil.

Diasorin SpA Total Operating Expense Historical Data

The historical data trend for Diasorin SpA's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Total Operating Expense Chart

Diasorin SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 272.79 383.37 525.29 503.34 516.66

Diasorin SpA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.00 127.03 125.00 135.66 131.00

Diasorin SpA Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €519 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » Total Operating Expense
Comparable Companies
TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT LH DGX XPAR:BIM ILMN XPAR:ERF EXAS RVTY ICLR QGEN MEDP
Traded in Other Exchanges
DSRLF:USA DIA:Italy 0GZX:UK 34D:Germany DIAS:Austria
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Website
https://www.diasoringroup.com
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines